CME Science Advanced PET Imaging, Nuclear Medicine, and Therapy From Diagnostics to Theranostics 2025

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
Target Audience
This course is intended for practicing radiologists, nuclear medicine physicians and radiologic nurses, physician assistants, technologists, residents, fellows and others who are interested in the clinical applications of PET and PET/CT.
Course Objectives
At the conclusion of this course, participants will be able to:
• Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
• Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
• Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
• Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT
 
+ Topics:
Thursday, October 16, 2025

Time
Session
Speaker

7:30-8:00 AM
Check-In and Continental Breakfast, Mouton Meeting Room

8:00-8:45
Introduction to Theranostics
Phillip Kuo, MD, PhD

8:45-9:45
Update on Radioiodine Treatment for Thyroid Cancer and the Role of PET/CT
Don C. Yoo, MD

9:45-10:00
Questions and Answers, Coffee Service

10:00-11:00
Importance of Patient Preparation for PET/CT (Oncology and Cardiac Sarcoidosis)
Don C. Yoo, MD

11:00-11:45
PET/CT in Head and Neck Cancer
Don C. Yoo, MD

11:45-12:00
Questions and Answers

12:00-1:00 PM
Luncheon Sponsored by Lantheus, Alsace Room

1:00-2:00
Dopamine Transporter Imaging of Parkinsonian Syndromes
Phillip Kuo, MD, PhD

2:00-2:45
Case-based Review of PET/CT for Amyloid Imaging
Phillip Kuo, MD, PhD

2:45-3:00
Questions and Answers, Coffee Service

3:00-3:45
PSMA PET Optimizing Therapy Response Assessment
Don C. Yoo, MD

3:45-4:30
Update on Nuclear Medicine for Infection and Inflammation
Don C. Yoo, MD

4:30-5:15
Amyloid and Tau Brain PET rebooted: The New Era of Neurotheranostics for Dementia
Phillip Kuo, MD, PhD

5:15-5:30
Discussion, Questions and Answers

October 17, 2025

Time
Session
Speaker

7:30-8:00 AM
Check-In and Continental Breakfast, Mouton Meeting Room

8:00-9:00
Understanding the Role of PSMA-PET in Selecting Patients for PSMA-Targeted Therapy
Phillip Kuo, MD, PhD

9:00-9:45
Challenging and Instructive Abdomen and Pelvis PET/CT Rev
Don C. Yoo, MD

9:45-10:00
Questions and Answers, Coffee Service

10:00-10:45
Pearls and Pitfalls for FDG-PET
Phillip Kuo, MD, PhD

10:45-11:30
Challenging and Instructive Chest PET/CT Review
Don C. Yoo, MD

11:30-12:15
PET Imaging for the Differential Diagnosis of Dementia
Phillip Kuo, MD, PhD

12:15-12:30
Questions and Answers

12:30-1:30 PM
Break for Lunch on Own

1:30-2:30
PET/CT Case Conference Greatest Hits
Andrew Quon, MD

2:30-3:15
Prostate Cancer PET Imaging Cases
Andrew Quon, MD

3:15-4:15
Nuclear Medicine Theranostics: From PET Scans to Therapy
Andrew Quon, MD

4:15-4:45
Discussion, Questions and Answers